title: FDA should stand firm on stem-cell treatments.
mesh_terms: D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence / Q000592:standards; D006801:Humans; D007564:Japan; D061214:Patient Safety / Q000331:legislation & jurisprudence* / Q000592:standards; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000331:legislation & jurisprudence* / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration / Q000941:ethics* / Q000331:legislation & jurisprudence*